Use of an ETEC Proteome Microarray to Evaluate Cross-Reactivity of ETVAX Vaccine-Induced IgG Antibodies in Zambian Children

Mubanga, CynthiaSimuyandi, MicheloMwape, KapambweChibesa, KennedyChisenga, Caroline C.Chilyabanyama, Obvious N.Randall, ArloLiang, XiaowuGlashoff, Richard H.Chilengi, Roma2025-09-172023-May-010.3390/vaccines11050939https://pubs.cidrz.org/handle/123456789/11856Developing a broadly protective vaccine covering most ETEC variants has been elusive. The most clinically advanced candidate yet is an oral inactivated ETEC vaccine (ETVAXUse of an ETEC Proteome Microarray to Evaluate Cross-Reactivity of ETVAX Vaccine-Induced IgG Antibodies in Zambian Childrenhttps://pubmed.ncbi.nlm.nih.gov/37243042/